NP_002440.2
[Other Products]
NCBI GenBank Nucleotide #
|
[Other Products]
UniProt Primary Accession #
|
[Other Products]
UniProt Secondary Accession #
UniProt Related Accession #
Molecular Weight
28,897 Da
NCBI Official Full Name
homeobox protein MSX-2
NCBI Official Synonym Full Names
msh homeobox 2
NCBI Official Synonym Symbols
FPP; MSH; PFM; CRS2; HOX8; PFM1 [Similar Products]
NCBI Protein Information
homeobox protein MSX-2; msh homeo box 2; homeobox protein Hox-8; msh homeobox homolog 2
UniProt Protein Name
Homeobox protein MSX-2
UniProt Synonym Protein Names
Homeobox protein Hox-8
UniProt Synonym Gene Names
UniProt Entry Name
MSX2_HUMAN
NCBI Summary for MSX2
This gene encodes a member of the muscle segment homeobox gene family. The encoded protein is a transcriptional repressor whose normal activity may establish a balance between survival and apoptosis of neural crest-derived cells required for proper craniofacial morphogenesis. The encoded protein may also have a role in promoting cell growth under certain conditions and may be an important target for the RAS signaling pathways. Mutations in this gene are associated with parietal foramina 1 and craniosynostosis type 2. [provided by RefSeq, Jul 2008]
UniProt Comments for MSX2
MSX2: Acts as a transcriptional regulator in bone development. Represses the ALPL promoter activity and antogonizes the stimulatory effect of DLX5 on ALPL expression during osteoblast differentiation. Probable morphogenetic role. May play a role in limb-pattern formation. In osteoblasts, suppresses transcription driven by the osteocalcin FGF response element (OCFRE). Binds to the homeodomain-response element of the ALPL promoter. Defects in MSX2 are the cause of parietal foramina 1 (PFM1); also known as foramina parietalia permagna (FPP). PFM1 is an autosomal dominant disease characterized by oval defects of the parietal bones caused by deficient ossification around the parietal notch, which is normally obliterated during the fifth fetal month. Defects in MSX2 are the cause of parietal foramina with cleidocranial dysplasia (PFMCCD); also known as cleidocranial dysplasia with parietal foramina. PFMCCD combines skull defects in the form of enlarged parietal foramina and deficient ossification of the clavicles. Defects in MSX2 are the cause of craniosynostosis type 2 (CRS2); also known as craniosynostosis Boston-type (CSB). CRS2 is an autosomal dominant disorder characterized by the premature fusion of calvarial sutures. The craniosynostosis phenotype is either fronto-orbital recession, or frontal bossing, or turribrachycephaly, or cloverleaf skull. Associated features include severe headache, high incidence of visual problems (myopia or hyperopia), and short first metatarsals. Intelligence is normal. Belongs to the Msh homeobox family.
Protein type: Transcription, coactivator/corepressor; DNA-binding
Chromosomal Location of Human Ortholog: 5q35.2
Cellular Component: transcription factor complex; nucleus
Molecular Function: protein binding; sequence-specific DNA binding; transcription cofactor activity; transcription factor binding
Biological Process: transcription from RNA polymerase II promoter; embryonic forelimb morphogenesis; negative regulation of keratinocyte differentiation; negative regulation of transcription from RNA polymerase II promoter; chondrocyte development; positive regulation of catagen; negative regulation of fat cell differentiation; embryonic hindlimb morphogenesis; osteoblast development; osteoblast differentiation; anterior/posterior pattern formation; positive regulation of osteoblast differentiation; negative regulation of cell proliferation; negative regulation of transcription, DNA-dependent; inhibition of CREB transcription factor; positive regulation of BMP signaling pathway; wound healing, spreading of epidermal cells; negative regulation of apoptosis
Disease: Parietal Foramina; Parietal Foramina With Cleidocranial Dysplasia; Craniosynostosis 2
Research Articles on MSX2
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice. It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Products associated with MSX2 elisa kit
Pathways associated with MSX2 elisa kit
Diseases associated with MSX2 elisa kit
Organs/Tissues associated with MSX2 elisa kit
|